SMITHER JOHN W sold 15.4% of their position (1.60K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Open‑market sale worth $40.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/9/2026ACC: 0001193125-26-386508
Director
Since Dec 2023
-1.60K
Net shares
Net seller
$40.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.60K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−1.60K
Price / share
$25.32
Trade value
$40.51K
% of position
15.4%
9/4/2026
10.36K→8.76K
Total
Net shares
−1.60K
Net value
-$40.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/4/2026 | S · Sale | −1.60K | $25.32 | $40.51K | 15.4% | 10.36K | 8.76K |
| Total | −1.60K | -$40.51K | ||||||
Derivative Transactions0
No derivative transactions reported